Evogene LtdNASDAQ:EVGNNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6695
- TODAY'S CHANGE (%)0.0098 (1.4855%)
- Bid / Lots0.6403/ 12
- Ask / Lots0.6680/ 3
- Open / Previous Close0.6650 / 0.6597
- Day Range
- 52 Week Range
- Volume22,459
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EVGN |
|---|---|---|
| 09:32 ET | 1122 | 0.665 |
| 09:57 ET | 321 | 0.665001 |
| 10:12 ET | 200 | 0.665 |
| 10:19 ET | 310 | 0.665 |
| 10:24 ET | 400 | 0.665 |
| 10:32 ET | 108 | 0.665 |
| 10:35 ET | 1000 | 0.679 |
| 12:34 ET | 300 | 0.66735 |
| 12:39 ET | 400 | 0.6651 |
| 01:03 ET | 510 | 0.665 |
| 01:06 ET | 300 | 0.6651 |
| 01:12 ET | 200 | 0.6673 |
| 01:30 ET | 7971 | 0.6695 |
| 01:32 ET | 352 | 0.67 |
| 01:44 ET | 100 | 0.6699 |
| 02:26 ET | 303 | 0.661588 |
| 02:42 ET | 249 | 0.6616 |
| 02:54 ET | 5970 | 0.6695 |
| 03:27 ET | 167 | 0.665001 |
| 03:57 ET | 848 | 0.6695 |
| 03:59 ET | 350 | 0.6695 |
Apr 16, 2024
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, from 7:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 11, 2024
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting, from 7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 2, 2024
Mar 28, 2024
Evogene Announces Filing of Annual Report on Form 20-F, from 9:00AM ET on Thursday Mar 28, 2024 by Dow Jones
9:00AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evogene Ltd | 33.4M | -1.3x | --- |
Palatin Technologies Inc | 28.2M | -0.7x | --- |
Singular Genomics Systems Inc | 30.6M | -0.3x | --- |
Marker Therapeutics Inc | 39.4M | -2.8x | --- |
Dare Bioscience Inc | 29.9M | -0.8x | --- |
Bolt Biotherapeutics Inc | 42.3M | -0.7x | --- |
Company Information
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Contact Information
- Headquarters
- 13 Gad Feinstein Street, Park RehovotREHOVOT, Israel 7638517
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Sarit Firon
- President, Chief Executive Officer
- Ofer Haviv
- Chief Financial Officer
- Dorit Kreiner
- Chief Executive Officer of AgPlenus Limited
- Brian Ember
- Chief Executive Officer of Biomica Limited
- Elran Haber
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.4M |
|---|---|
Revenue (TTM) | $5.6M |
Shares Outstanding | 50.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.49 |
EPS | $-0.53 |
Book Value | $0.24 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -470.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
